of calpain in cerebral tissue differ in the composition of the catalytic subunit and in the cell of origin. CaJpain I (J-L-calpain) is localized to neurons and may be activated in the presence of micromolar concentrations of calcium, Calpain II (m-calpain) is present in glial cells and in axonal tracts, but must be exposed to millimolar concen trations of calcium to be activated. The intracellular con centration of calcium in ischemic neurons will reach the micromolar range required for activation of calpain I, due to the release of ion from stores within cellular or ganelles or enhancement of calcium conductance from the extracellular space (Siesjo, 1988) . Calcium-mediated activation of cal pain begins with the translocation of pro calpain to a target substance in the cell membrane or cytoskeleton, followed by autolytic transformation of the precursor to the active calpain moiety. Once activated, calpain may cause proteolysis of neurofilaments, MAPs, and other cytoskeletal proteins before returning as a soluble, inactive form to the cytoplasm (Suzuki and Ohno, 1990) . Roberts-Lewis et at (1994) have developed a family of antibodies that recognize cal pain-cleaved spectrin in gerbil brain. Immunostaining with one of these antibod ies, Ab-37, became intensified in CAl pyramidal neu rons after 5 min of bilateral common carotid artery (CCA) occlusion. Immunoreactivity persisted from 24 to 48 h after reversal of occlusion and correlated with the weJl-recognized vulnerability of CA I neurons to ceJlular death associated with reperfusion following global isch emia (Kirino, 1982; Pulsinelli et aI., 1982; Smith et aI., 1984) . Immunostaining was also observed in the neocor tex, striatum, and thalamus as early as 30 min after re versal of carotid occlusion, but had begun to fade after 24 h. These results confirm that persistence of Ab-37 im munoreactivity is associated with calpain-induced cyto skeletal proteolysis and neuronal degeneration in global cerebral ischemia. We hypothesized that a similar rela tionship between calpain activity and neuronal death may apply during maturation of a cerebral infarct. We tested this hypothesis by using Ab-37 as a functional assay of calpain activity in a well-established model of focal brain infarction in the rat. We performed immuno cytochemical studies, double-labeled immunofluorescent imaging, and Western blot analysis to demonstrate the effect of calpain on MAPs in ischemic brain tissue. CCA-middle cerebral artery (MCA) occlusion was performed by a modification of the technique described by Brint et al. (1988) . All rats were fasted overnight prior to surgical prepa ration. Each animal was anesthetized via intraperitoneal injec tion with 0.5 mg/g chloral hydrate for isolation of the MCA and CCA. One femoral artery was cannulated for blood sampling and measurement of MABP. Arterial blood was sampled 10 min before CCA-MCA occlusion in each animal prepared for immunocytochemical studies (group A; see below) and used to determine pH, P,,02' P"c02, hematocrit (Hct). and glucose. Rec tal and temporalis muscle temperatures were maintained at 36-37°C by external warming. The left CCA was isolated through an anterior incision in the neck. For identification of the ipsi lateral MCA, a second incision was made between the lateral canthus of the left eye and the corresponding external auditory canal to bare the underlying skull. The MCA was exposed through a 2-mm burrhole drilled 2-3 mm rostral to the fusion of the zygomatic arch and the squamosal bone under direct visualization with a Zeiss operating microscope. The dura was opened with a sharp needle, and an alloy wire (0.1 mm diam eter) was inserted beneath the MCA just superior to the inferior cortical vein. The MCA was elevated from the cortical surface and cauterized by applying electrical current to the wire. The CCA was tied off with 4-0 silk and both incisions were closed.
Materials and Methods

Focal cerebral ischemia
The animal was then returned to its cage and given free access to water and rat chow.
Thirty-two rats (group A) were killed and prepared for im munocytochemical studies after permanent CCA-MCA occlu sion lasting for 15 min or 1, 6, 24, or 72 h (n = 5 or 6 at each time point). Group A also included five sham-ischemic animals subjected to nonocclusive manipulation of the left CCA and craniotomy performed without opening the dura before being killed for immunocytochemical studies 24 h later. An addi-J Cereb Blood Flow Meulb. Vol. 16, No.6, /996 tional 16 animals (group B) underwent permanent CCA-MCA occlusion for 15 min or 1, 6, or 24 h (n = 4 at each time point), before being killed for sampling of normal and ischemic brain tissue used in Western blot analysis.
Primary antibodies
The primary antibodies used for immunocytochemical stud ies and Western blot analysis included anti-MAP2 (clone AP20, Boehringer-Mannheim Corporation, Indianapolis, IN, U.S.A.), Ab-37 (gift from Dr. Robert Siman of Cephal on, In corporated, West Chester, PA, U.S.A.). and anti-T protein (T-I, Boehringer-Mannheim Corporation). The AP20 monoclonal antibody recognizes all isoforms of dendrite-specific MAP2.
Ab-37 is a polyclonal antibody that identifies a proteolytic fragment of spectrin produced by activated calpain (Roberts Lewis et aI., 1994) . The anti-T monoclonal antibody recognizes a phosphorylation-sensitive, nonphosphorylated epitope usu ally confined to axons (Binder et aI., 1985) . However, enzy matic dephosphorylation of tissue sections taken from adult rat brain will enhance T-I immunoreactivity in somatodendritic structures (Papasozomenos and Binder, 1987) . Our Western blot studies were designed to include a second anti-T monoclo nal antibody, 8CII (Athena Neurosciences, South San Francis co, CA, U,S.A.), that identifies a phosphorylation-independent epitope. Whereas T-I will recognize only nonphosphorylated protein, 8C II will immunolabel all isoforms of T. Optimal dilutions of all primary antibodies were verified in preliminary experiments and in 'recent publications from our laboratory (Geddes et aI., I 994a,b; Schwab et aI., 1994) . Production, char acterization, and specificity have been described for each an tibody IAP20 (Binder et aI. , 1986); Ab-37 (Roberts- Lewis et aI., 1994; Geddes et aI., 1995) ; T-I (Binder et aI., 1985; Papa sozomenos and Binder. 1987; Szendrei et aI., 1993) ; 8CII (Vigo-Pelfrey et aI., 1995) ], In the present study, controls for the specificity of the immunostaining included testing of pri mary antibodies in Western blots containing purified target antigen and omission of the same antibodies from immunocy tochemical preparations (Schwab et aI., 1994) .
Immunocytochemistry and double-labeled immunofluorescence
After the designated period of CCA-MCA occlusion, each rat in group A was reanesthetized with an intraperitoneal in jection of 0.5 mg/g chloral hydrate and perfused transcardially with 50 ml of heparinized normal saline, followed by 200 ml cold 4% paraformaldehyde in phosphate buffered saline (pH 7.4), The brain was removed and stored in the same fixative for 24 h, before being cryoprotected in 30% sucrose and frozen in powdered dry ice. The frozen brain was stored at -70°C before being cut into 30-f,Lm coronal sections with a Leitz freezing sledge microtome. Three changes of Tris-buffered saline (TBS; 50 mM, pH 7,5) were used to rinse free-floating tissue sections.
Endogenous peroxidase activity was blocked with 3% hydro gen peroxide followed by transfer of the sections into TBS containing 0, I % Triton X-100. All tissue sections designated for immunolabeling of MAP2 or T protein were then incubated with 1.5% normal horse serum, while those chosen for Ab-37 immunostaining were exposed to 1.5% normal goat serum.
Sections prepared for immunolabeling of MAP2 or T protein were incubated overnight in a solution of primary antibody (AP20 I: 10,000; T-I I :20,000) maintained at room tempera ture. Other sections used to demonstrate calpain-mediated spec trin proteolysis were incubated with Ab-37 (I: 10,000) under the same conditions. Biotinylated secondary antibodies were used for identification of AP20 and T-l (anti-mouse pread sorbed against rat serum, Vector Laboratories, Burlingame, CA, U.S.A.) or Ab-37 (anti-rabbit, Zymed Laboratories, Inc., of immunostaining was conducted on brain sections obtained from the group A rats and exposed to the AP20, Ab-37, or T-l antibodies. The region of altered immunoreactivity within isch emic tissue was outlined in each coronal section and the optical density was determined in comparison to the equivalent area in the opposite hemisphere. Two tissue sections were examined for each animal and averaged to yield a final result.
After completion of the immunocytochemical studies, se lected specimens were prepared for double-labeled immunoflu orescence to determine if there was a temporal or spatial cor relation between the cytoskeletal changes and the activation of calpain. Tissue sections were blocked in 1.5% horse and 1.5% goat serum before being incubated with both the mouse mono clonal AP20 (I :2,000) and the rabbit polyclonal Ab-37
(1:7,500) overnight at room temperature. The sections were washed three times in TBS and incubated for 1 h with a fluo rescein isothiocyanate (FITC)-conjugated horse anti-mouse secondary antibody (Vector). To maximize the . specificity of the Ab-37 antibody, the same sections were incubated for I h each with a biotinylated goat anti-rabbit secondary antibody and Texas Red avidin D (both Vector products). The sections were mounted on glass slides, cover-slipped with VectaShield to retard quenching of the f1uorescent signal, and viewed with the Olympus BH2 microscope equipped for epif1uorescence and filtered to differentiate the FITC and Texas Red f1uro phores.
Western blot analysis
Each animal in group B was reanesthetized with an intra peritoneal injection of 0.5 mg/g chloral hydrate, as described in the preceding paragraphs. It was then perfused transcardially with 30 ml of 15% India ink (v/v) diluted in normal saline. The was conducted with 6.5% gels, but T protein fractions were separated on preformed 10-20% linear gradient gels (Millipore, Bedford, MA, U.S.A.). A standard supernatant prepared from normal rat cortex was applied to each gel to ensure reproduc ibility and allow comparison of assays. The proteins were trans ferred electrophoretically onto polyvinylidene tluoride mem branes (Millipore) and immunoreacted with the antibodies of interest (AP20 1:1,000; T-I 1:2,000; SCI I 1:10,000). Formal 
Statistical analysis
The physiologic data obtained from group A animals were expressed as means ± SD. Mean whole blood glucose levels, Hct, and arterial blood pH, P"co2, and P"02 were compared between subgroups identified by duration of CCA-MCA oc clusion, using Kruskal-Wallis one-way analysis of variance (ANOV A) on ranks. The mean optical density measurements made on unaffected and ischemic tissue immunolabeled with the different primary antibodies were tested by the same method, followed by post hoc analysis with paired t tests. Den sitometric readings of Western blots performed to determine the concentration of MAP2 and T protein in the ischemic and unaffected cOl1ex were compared by the same approach under taken for the optical densities calculated from tissue sections, except that post hoc analysis was conducted with the Student Newman-Keuls method for nonparametric multiple compari sons.
RESULTS
Physiologic data obtained from the arterial blood samples in group A confirmed that all animals were uni formly stable prior to CCA-MCA occlusion. There was nO significant difference in any of the physiologic vari ables compared between subgroups defined by the dura tion of ischemia. Aggregate data compiled from arterial blood gas samples taken from all of the subgroups showed P aOZ 70 ± 9 mm Hg, P aco2 57 ± 6 mm Hg, and pH 7.26 ± 0.09. The hypercapnea and mild respiratory acidosis resulted from suppression of ventilatory rate in animals anesthetized with chloral hydrate. The whole blood glucose level taken from the same aggregate data set was 4.8 ± 0.6 mmollL and Hct was 52 ± 2%. Mean arterial blood pressure was 91 ± 17 mm Hg across all subgroups.
Immunocytochemistry of MAP2 Figure I shows representative 30-J,lm coronal sections of brain taken from the right cerebral hemisphere serving as an unaffected control and the left hemisphere demon strating ischemic tissue sampled at 15 min or 1, 6, 24, or 72 h after initiation of CCA-MCA occlusion. Each sec-
Representative 30 )Jm coronal sections of rat brain taken from the unaffected right hemisphere (C) or the ischemic left hemisphere between 15 min and 72 h after initiation of CCA-MCA occlusion. All photographs were taken at 1 x magnification. The loss of MAP2 immunostaining by the AP20 antibody is gradual, beginning in isolated patches of ischemic tissue between 15 min and 1 h and progressing to complete absence of signal within the infarct zone after 24 h. Corresponding inversely to the loss of MAP2 signal is a gradual increase in the intensity of immunostaining with the Ab-37 antibody, representing accumulation of spectrin breakdown products resulting from calpain-mediated proteolysis. Tau-1 immunostaining of nonphosphorylated T protein becomes intensified within the infarct zone as early as 15 min after CCA-MCA occlusion, but appears diminished in the adjacent transition area representing the ischemic penumbra. This apparent concentration of T-1 immunostaining persists for 6 h, but decreases gradually between 24 and 72 h. The scale bar represents 2 mm.
tion was immunostained with AP20 identifying all iso forms of MAP2, 'T-I recognizing a nonphosphorylated epitope of 'T protein, or Ab-37 labeling calpain-cleaved spectrin by-products. The pattern of immunoreactivity observed with the AP20 antibody was identical in unaf fected hemispheres and in sham-ischemic controls. The antibody labeled MAP2 fibers in healthy dendrites ( Fig.  2A) , as described in previous reports (Bernhardt and Ma tus, 1984; DeCamilli et a!., 1984) . Immunoreactivity was relatively consistent across cortical regions but was much fainter in the striatum. At higher magnification, a rich plexus of fiber staining was evident in the molecular layer of cerebral cortex. Layers 3 and 4 of the cortex featured prominent immunolabeling of straight apical dendrites and fainter background staining of dendritic branches. In layer 5, neuronal perikarya were only faintly immunostained (Fig. 3A) .
Within 15 min of CCA-MCA occlusion, the dendritic processes of some neurons within the infarct had become coiled (Fig. 2B ). Fine dendritic processes appeared less intense in ischemic tissue, such that the surviving apical dendrites stood out against an unstained background. Af ter I h of CCA-MCA occlusion, MAP2 immunoreactiv ity appeared patchy within the infarct zone and could not be detected in the dorsolateral aspect of the ipsilateral striatum (see AP20 immunolabeling in Fig. I) . The loss of MAP2 immunolabeling was most prominent in layers 5 and 6 of ischemic cortex, as well as in the outer mo-f-
Representative photomicrographs (x40) of alterations in dendritic MAP2 immunoreactivity during focal ischemia. In the unaffected right hemisphere (A) of an animal subjected to 15 min of CCA-MCA occlusion, MAP2 immunoreactivity is prominent in apical dendrites but is also evident in finer dendritic branches. In cortical tissue sectioned from the ischemic left hemisphere of the same rat (B), apical dendrites appear coiled and more intensely immunostained. The diffuse immunoreactivity of the neuropil is less intense than is shown in the unaffected hemisphere. In tis sue subjected to 1 h of CCA-MCA occlusion (e), coiled apical dendrites remain visible whereas background immunostaining is largely absent. The scale bar represents 50 iJm. lecular layer. Toward the boundary of the infarct adja cent to the transition zone representing the ischemic pen umbra, MAP2 immunostaining was diminished across all cortical layers. Coiled dendrites were abundant in the regions of decreased MAP2 immunostaining (Fig. 2C ). Increased perikaryal MAP2 immunoreactivity was also evident (Fig. 3B) , particularly in the transition area. After 6 h of ischemia, MAP2 immunolabeling was markedly diminished in the infarct zone (see AP20 immunolabel ing in Fig. I) . While some apical dendritic fragments were visible, neuronal perikarya and the background neuropil were not immunostained. The infarct zone re mained devoid of MAP2 immunostaining after 24 and 72 h of ischemia. There was an abrupt transition between the infarct and adjacent normal tissue, with an occasional neuron in the transition zone displaying enhanced peri karyal MAP2 immunoreactivity.
Immunocytochemistry of cal pain-cleaved spectrin fr agments As shown in Fig. 1 , no specific Ab-37 immunoreac tivity was observed in normal, nonischemic tissue. Scat tered neuronal perikarya were visible in unaffected cor tex of ischemic animals in both hemispheres of sham ischemic rats, but the staining intensity was barely above background. After 15 min of CCA-MCA occlusion, iso lated neurons within the infarct zone displayed enhanced perikaryal immunostaining (Fig. 3C ). After 1 h of isch emia, neuronal perikarya were labeled more intensely, with immunoreactivity also evident in apical dendrites (Fig. 3D) . The staining intensity of background neuropil was increased throughout the infarct zone. Figure 1 shows that intense Ab-37 immunolabeling was observed in a discrete region of the dorsolateral striatum ipsilateral to the cortical infarct in two of five rats, corresponding to the loss of MAP2 immunoreactivity seen in the same region. At 6 h following arterial occlusion, intense Ab-37 immunolabeling was evident throughout the infarct in all animals studied. Neuronal perikarya were no longer stained, but dendrites remained immunopositive. Of the five rats examined at this time point, one showed peri karya immunostaining of isolated cells in the striatum contralateral to the infarction, a second animal displayed perikaryal immunolabeling in cells of the ipsilateral re ticular thalamic nucleus, and a, third exhibited a large patch of immunostaining in the ipsilateral striatum. After 24 h of ischemia, Ab-37 immunostaining of the infarct remained intense and well demarcated in four of the five animals examined. The remaining animal showed no dif ference in Ab-37 immunoreactivity of ischemic tissue compared to its unaffected cortex or sham-ischemic con trols. After 72 h of CCA-MCA occlusion, Ab-37 immu noreactivity persisted in the infarct zone and was also evident in the ipsilateral external capsule (3/6 rats), the lower ipsilateral cortex (1/6), and the striatum (2/6).
Immunocytochemistry of ,. protein
lmmunostaining with T-l in normal cortex was con fined primarily to axons, as reported originally by Binder et al. (1985) . In the cortex and striatum of sham-ischemic controls and in the unaffected hemisphere of animals immunoreactivity becomes intensified within perikarya of isch emic neurons. C: Scattered neurons within ischemic tissue sampled after 15 min of CCA-MCA occlusion show perikaryal immunostaining with the Ab-37 antibody. In tissue reacted with Ab-37 after 1 h of ischemia (0), spectrin breakdown products resulting from cal pain-mediated proteolysis have accumulated in many apical dendrites and remain in isolated neurons. E dem onstrates that perikaryal immunostaining with the 7-1 antibody becomes prominent in neurons within the transition zone repre senting the ischemic penumbra after 6 h of CCA-MCA occlusion. The scale bar represents 50 �m.
J Cereb Blood Flow Metab. Vol. 16. No. 6, 1996 subjected to CCA-MCA occlusion, i-I immunoreac tivity was present in the neuropil whereas neuronal perikarya remained unlabeled. There were regional dif ferences in i-I immunostaining of normal cortex. The frontoparietal region displayed prominent i-I immuno staining in cortical layers 3 and 4. However. this pattern of immunoreactivity was not seen in primary olfactory cortex, which had a clear zone in layer 2 and prominent labeling of the outer molecular layer. As is demonstrated in Fig. 1 , alterations in the normal pattern of i-I immu noreactivity were noticeable within 15 min of CCA MCA occlusion. There was enhancement of i-I immu nostaining within the infarct zone. while immunolabeling became diminished within the transition area represent ing the ischemic penumbra. This pattern was also evident after 1 and 6 h of arterial occlusion, when some rats displayed increased i-I immunostaining in the dorsolat eral striatum ipsilateral to the infarct (Fig. 1) . Perikaryal immunostaining of neurons within the transition zone between ischemic. and unaffected tissue became increas ingly prominent between I and 6 h ( Fig. 3E ). After 24 h of ischemia. i-\ immunoreactivity in the neuropil was reduced and had been rt;:placed by enhanced immuno staining in neuronal perikarya (Fig. 1) . Increased i-I immunoreactivity was also evident in cells, presumably oligodendroglia, found in the corpus callosum. At 72 h, i-I immunoreactivity was diminished in the infarct zone and perikaryal immunostaining was no longer observed ( Fig. 1) .
Cresyl violet
Cresyl violet stallllllg has been used previously to measure the brain infarct area in animal models of arte rial occlusion (Benveniste et al., 1991) . In this study, we relied upon tissue staining with cresyl violet as a quali tative measure demonstrating the progressive loss of neuronal architecture over time. We sought to determine the correlation between the early changes in the distri bution of i protein. MAP2, or calpain-cleaved spectrin and the alteration of Nissl substance stained by the cresyl violet. Figure 4 shows that only healthy cells with good laminar detail were observed in the unaffected cortex (C), as expected. There was no significant difference in cresyl violet staining of cells in the unaffected cortex and those in the infarct zone after 15 min of CCA-MCA occlusion. After \ h of ischemia, there was minimal loss of staining but no pyknosis or neuronolysis. After 6 h of arterial occlusion, inspection of ischemic cortex showed shrinkage of neuronal volume with an inflammatory in filtrate in one animal and loss of approximately 30% of cells in another. By 24 h, the infarct zone had developed islands of necrosis with loss of 50-70% of neurons in all animals. Complete loss of cells occurred after 72 h, and the infarct zone appeared uniformly necrotic. Optical density measurements Figure 5 shows optical densities measured from nor mal and ischemic cortex obtained from group A animals and processed for immunolabeling of MAP2, cal pain cleaved spectrin, and T protein. The upper panel in Fig. 5 reveals data acquired from tissue immunolabeled with the AP20 antibody used to identify MAP2. Comparison of group means using the Kruskal-Wallis ANOYA re vealed that MAP2 immunoreactivity differed signifi cantly in the infarct zone over varying durations of isch emia (p � 0.002). Post hoc analysis by paired t testing confirmed that ischemic tissue was significantly less im munoreactive than unaffected cortex after 1 (p � 0.05), 6 (p � 0.0001),24 (p � 0.0001), and 72 (p � 0'()2) h of CCA-MCA occlusion.
The middle panel of Fig. 5 shows mean optical den sities measured from ischemic cortex immunolabeled with Ab-37 to identify calpain-cleaved spectrin. Kruskal -Wallis ANOYA again revealed a highly significant dif-ference between optical density means in groups sampled at varying durations of ischemia (p � 2.0 x lO-lO ). Post hoc analysis showed that immunoreactivity of calpain-cleaved spectrin rose significantly in ischemic cortex at 6 (p � 0.02), 24 (p � 0.0001), and 72 (p � 0.00 1) h. The lower panel of Fig. 5 shows mean optical densities measured from unaffected and ischemic cortex immunolabeled with T-l . Kruskal-Wallis ANOYA re vealed a significant difference between optical density means calculated for ischemic tissue in groups sampled at varying times (p � 0.002). Post hoc analysis demon strated that the increased T-l immunoreactivity observed in the infarct zone at 6 h differed significantly from the baseline signal in the unaffected cortex (p � 0.002).
Quantitative Western blot studies
We performed quantitative Western blot analysis to determine if the qualitative differences in immunoreac tivity between normal and ischemic cortex were associ- Histogram of mean optical densities (ODs) ± SO measured in immunocytochemical specimens prepared from animals subjected to varying dura tions of ischemia (n = 5 or 6 for each sampling time). An overall mean 00 measured from unaf fected cortex in all animals (n = 32) is shown for interpretive convenience. For AP20 immunolabel ing, the mean 00 in ischemic tissue was signifi cantly lower than that measured in unaffected cor tex taken from the same animals after 1, 6, 24, and 72 h of CCA-MCA occlusion. For Ab-37, mean 00 in ischemic cortex differed significantly from unaf fected tissue at 6, 24, and 72 h. For the T-1 anti body, only the relative increase in immunoreactivity measured in ischemic tissue at 6 h was significantly different from unaffected cortex. CCA-MCA occlusion extended to 24 h. This time dependent loss of MAP2 protein correlated with the dis appearance of MAP2 immunoreactivity observed in the infarct zone after 6 h, as shown in Fig. I.  Figure 7 contains two photographic images of the same samples displayed in Figure 6 , but now immu noreacted with 1"-1 (panel A) or 8C II (panel B). Im munolabeling with either antibody reveals that a well-demarcated pair of bands exceeding 48.5 kDa was observed in unaffected cortex. This doublet lost immu noreactivity and converted into a single band as the du ration of CCA-MCA occlusion extended to 24 h. Cor respondingly, a single band of lower molecular weight observed in unaffected cortex became more pronounced Panel B shows the same set of samples processed for identifi cation of a phosphorylation-independent epitope by the 8C1 1 antibody. The upper arrow to the right of both panels indicates a well-defined pair of bands in unaffected cortex that loses immu noreactivity and converts into a single band as the duration of CCA-MCA occlusion extends to 24 h. The lower arrow to the right of both panels identifies a single band that becomes more immunoreactive as ischemia is prolonged. Molecular weight markers in kilodaltons are shown on the left margin of both pan els.
as ischemia progressed. This reciprocal phenomenon suggests that dephosphorylation of 1" protein occurs as cortical tissue becomes more ischemic, correlating with our observation of a similar process in postmortem brain (Schwab et aI., 1994) .
To better characterize the alterations in 1" and MAP2 proteins, laser densitometry was performed on Western blot of unaffected and ischemic cortex sampled between 15 min and 24 h of MCA-CCA occlusion (Fig. 8 ). For this quantitative analysis, 1" protein was identified only by the 1"-1 antibody. Comparison of optical density val ues associated with MAP2 quantified in ischemic cortex showed that there was heterogeneity of group means de tected by Kruskal-Wallis ANOYA (p � 0.04). Post hoc testing demonstrated that the mean optical density rep resenting MAP2 antigen in ischemic cortex sampled at 24 h was significantly lower than those obtained at ear lier time points (p � 0.05). The optical densities associ ated with MAP2 antigen in unaffected cortex remained uniform across all sampling times. There were no sig nificant differences in optical densities associated with 1" protein in unaffected or ischemic tissue.
Double-labeled immunofluorescence
To determine the temporal and spatial relationship be tween cytoskeletal alterations and the activation of cal pain in individual neurons affected by ischemia, tissue sections taken from group A animals were incubated simultaneously with AP20 and Ab-37 complexed with fluorescently labeled secondary antibodies. All images used for this double-labeled immunofluorescence tech nique were taken from within the infarct, avoiding the transition zone between ischemic and unaffected tissue. As is shown in Fig. 9B , perikaryal Ab-37 immunoreac tivity was already apparent after 15 min of MCA-CCA occlusion. The same region immunolabeled with AP20 ( Fig. 9A ) showed no somal accumulation of MAP2. To better delineate when somal accumulation of MAP2 would be seen after calpain activation occurred at 15 min, three rats were subjected to 30 min of arterial oc clusion and added to those already prepared for later time points in group A. Representative photomicrographs taken of the ischemic tissue in one of these animals are shown in Fig. 9 (C and D) and demonstrate that somal accumulation of MAP2 and calpain-activated spectrin proteolysis colocalized in the same ischemic neurons. Identical findings were noted in the other two rats in the 30-min group. This colocalization of AP20 and Ab-37 immunolabeling persisted in animals subjected to 60 min of CCA-MCA occlusion (data not shown). However, prolonging cortical ischemia to 6 h produced little de monstrable perikaryal MAP2 immunoreactivity and caused fragmentation of Ab-37 immunofluorescent la beling (data not shown). Surprisingly, somatic MAP2 immunoreactivity reappeared in neurons located within Ischemic Tissue the infarct after 24 h of CCA-MCA occlusion (Fig. 9E) .
Although there was widespread Ab-37 immunofluores cent labeling within the same area at 24 h ( Figure 9F ), only rarely did cells coexpress both activities. Photomi crographs of ischemic tissue obtained after 72 h of arte rial occlusion were not included in Fig. 9 , because the severity of necrotic damage prevented reliable interpre tation of the immunofluorescent labeling.
DISCUSSION
The results of this study show that focal cerebral isch emia causes acute changes in cytoskeletal structure that predate histological features of neuronal death observed in a mature infarction. The alterations observed in our immunocytochemical experiments clearly preceded mi croscopic evidence of widespread cellular necrosis re vealed by cresyl violet staining. The most sensitive in dicator of ischemic neuronal change was the coiled, dis figured appearance of apical dendrites, as documented by AP20 immunostaining of MAP2 protein after 15 min of CCA-MCA occlusion. Prolongation of ischemia to 6 h caused almost complete loss of AP20 immunolabeling throughout the infarct zone, matched by the disappear ance of dendritic branches that began at I h. The loss of AP20 immunostaining corresponded inversely to the si multaneous accumulation of calpain-cleaved spectrin breakdown products, represented by Ab-37 immunore activity. The immunocytochemical studies demonstrate that intraneuronal MAP2 proteolysis is a sensitive, early marker of focal ischemic injury in brain. The double labeled immunofluorescence experiments, when com bined with our immunocytochemical work, suggest that proteolytic disassembly of MAP2 coincides with calpain activation.
To our knowledge, this is the first report of temporal and spatial patterns of cytoskeletal disruption correlated with immunocytochemical evidence of calpain-mediated proteolysis in focal cerebral ischemia. The Ab-37 experi ments correlate well with previous descriptions of sus pected calpain activity in focal ischemia. Bartus et al (l995a) found similar evidence of calpain activation in rat cerebral tissue subjected to permanent MCA occlu sion. These investigators performed Western blot studies demonstrating that spectrin breakdown products increase significantly after 1 h of ischemia, long before the de velopment of an infarct. Their results also indicated that calpain-mediated spectrin proteolysis peaked after 12 h of permanent MCA occlusion and continued through 24 h. Although the present study did not include sampling of brain tissue at 12 h of focal ischemia, our observations of calpain activation and MAP2 proteolysis support the ob servations of Bartus et al. Hong et al. (1994b) ischemia. In this setting, Western blot analysis showed that spectrin breakdown products generated within the infarct zone reach a plateau after 3 h of reperfusion. Spectrin proteolysis in the transition zone corresponding to the ischemic penumbra followed a biphasic course, with a modest increase in breakdown products occurring after 2 h of reperfusion and a much larger elevation taking place at 24 h. The same differentiation between cytoskeletal damage within the infarct zone and the ad joining penumbral region has been shown in photo chemically induced MeA occlusion by Yao et a!. (1995) , who suggested that enhanced spectrin proteolysis may result from suppression of glucose metabolic rate in isch emic tissue.
In comparison to our findings, a previous study by Inuzuka et a!. (1990) failed to detect suppression of MAP2 immunoreactivity earlier than 6 h following per manent MeA occlusion. This apparent delay in reduction of MAP2 may be attributed to sampling of ischemic tissue no earlier than 4 h after occlusion of the MCA or the use of immunoblots in place of immunocytochemis try. Inuzuka et a!. performed blotting assays designed to show the protein content of the entire cerebral hemi sphere subjected to MCA occlusion, thereby mixing un affected and ischemic tissue together. They were unable to observe the profound changes in MAP2 shown in our immunocytochemical experiments conducted at or be fore 6 h of ischemia. Our results suggest that immuno cytochemical techniques are more sensitive than blot studies in detecting loss of MAP2. Both approaches were able to identify significant alterations in MAP2 immu noreactivity, but the blotting assays produced consistent results only in tissue that had been rendered ischemic for 24 h.
Our immunocytochemical experiments revealed peri karyal accumulation of MAP2 immunoreactivity in neu rons within the transition zone corresponding to the isch emic penumbra. This effect was observed after no more than 1 h of ischemia. We speculate that this apparent redistribution of MAP2 antigen occurred following cal pain activation and loss of dendritic branches. Our im munofluorescent studies showed robust labeling of so mal MAP2 protein in isolated neurons confined to tissue that had been ischemic for 24 h. The reappearance of somal MAP2 immunoreactivity may represent the final breakdown and collapse of MAP2 fibers within the neu ronal cell body, following an initial accumulation of MAP2 antigen from dendrites injured during the early stage of the ischemic injury. Another possibility is that the ischemic tissue response was heterogeneous, with small groups of neurons surviving to display perikaryal accumulation of MAP2 immunoreactivity after others had already died. Our cresyl violet studies showed a loss of 50-70% of neurons in all animals at 24 h, implying that isolated cells could have remained intact long J Cereli Blood Flow Metab. Vol. 16, No. 6, 1990 enough to demonstrate what would otherwise be an early indicator of ischemic stress. This observation parallels the findings of Bartus et a!. (l995a), who performed a time-course study of neuronal changes following perma nent, focal MCA ischemia. They noted that cell loss occurs progressively in the ischemic neocortex but dis covered that a limited number of small, triangulated cells remain viable even after 24 h of MeA occlusion. Lastly, it is not inconceivable that the delayed immunofluores cent labeling may represent synthesis of new MAP2 fi bers to replace those lost from apical dendrites. Saito et a!. (1995) showed that the mRNA transcript for MAP2c, a developmentally regulated isoform present in fetal brain, increased in the CA 1 region of the rat hippocam pus 12-48 h after transient global ischemia produced by cardiac arrest. These results, when correlated with our double-labeled immunofluorescence work, suggest that injured neurons may reexpress a MAP2 isoform as a late postischemic response. However, our Western blot stud ies performed on ischemic tissue obtained at 24 h did not reveal a low-molecular-weight protein that could repre sent MAP2c produced under these conditions.
Tau immunostaining was also altered in response to focal ischemia, but in a-manner distinct from MAP2. Tau dephosphorylation throughout the infarct zone was evi dent as early as 15 min following ischemia. The peri karyal accumulation of 'T preceded its disappearance, al though both events were delayed as compared to MAP2. Our group has reported 'T dephosphorylation and peri karyal accumulation following reversible forebrain isch emia (Geddes et aI., 1994b) and in the postmortem rat brain (Schwab et a!., 1994) . In the present study, peri karyal T accumulation was most evident in the ischemia penumbra, but was not observed in all neurons that were destined to become necrotic in the core of the infarction. This is consistent with our previous discovery that peri karyal 'T accumulation is a sensitive marker of neuronal stress caused by reversible forebrain ischemia but is not absolutely predictive of neuronal death (Geddes et aI., 1 994b ). Using the T antibody, it is difficult to estimate relative T levels as the intensity of staining is dependent upon both 'T protein levels and the degree of phosphor ylation at the 'T-l epitope. The phosphorylation independent T antibody, 8C 11, confirmed that 'T is resis tant to proteolysis following focal ischemia, as compared to MAP2. This finding contrasts with in vitro studies, in which 'T and MAP2 are both sensitive to calpain mediated proteolysis (Johnson et aI., 1989 (Johnson et aI., , 1991 . The vulnerability of or to calpain-mediated proteolysis is in fluenced by its localization, phosphorylation, and its as sociation with microtubules. Highly phosphorylated T protein in human paired helical filaments and bovine brain is more resistant to calpain proteolysis than normal of normal 'T does not further enhance vulnerability to calpain proteolysis (Litersky and Johnson, 1992; Liter sky et aI., 1993) . In situ, 'T dephosphorylation may in crease 'T binding to micro tubules (Lindwall and Cole, 1984) , increasing its susceptibility to calpain-mediated proteolysis (Johnson et aI., 1989) . The relative resistance of 'T observed following focal ischemia may reflect its predominantly axonal localization, in contrast to the so matodendritic localization of MAP2 and calpain (Binder et aI., 1986; Perlmutter et aI., 1988) .
In summary, the results of this study support the role of calpain in microtubular proteolysis associated with focal cerebral ischemia, but demonstrate that MAP2 and 'T are affected differently. Calpain-induced microtubular proteolysis is an early marker of ischemic neuronal stress, preceding cell death by several hours. Our data are consistent with previous reports suggesting that cal pain inhibition is neuroprotective in cerebral ischemia. Sev eral investigators have shown that pretreatment with cal pain inhibitors will preserve selectively vulnerable neu rons in rodent models of reversible forebrain ischemia (Lee et aI., 199 1; Rami and Krieglstein, 1993) . Bartus et al. (1995b) found that postischemic, intrahippocampal injection of a calpain inhibitor protected CAl neurons in the four-vessel occlusion model. Others have demon strated similar effects with calpain inhibitors adminis tered before or after the onset of focal brain ischemia (Hong et aI., 1994a; Bartus et aI., 1994a,b) . Our findings, when correlated with these published results, suggest that calpain inhibitors hold great promise for ameliorating cerebral injury caused by stroke .
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